PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1671847
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1671847
Autologous Cell Therapy Market, By Product Type, By Application, By Technology, By End User, By Geography
The Global Autologous Cell Therapy Market is estimated to be valued at USD 5.51 Bn in 2025 and is expected to reach USD 22.30 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 22.1% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 5.51 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 22.10% | 2032 Value Projection: | USD 22.30 Bn |
The global autologous cell therapy market has been witnessing significant growth in the recent years. Autologous cell therapy involves the collection of stem cells or other types of cells from patient's own body, modifying or expanding them through various processes and infusing back to the same patient to treat diseases. It provides an alternative therapeutic approach to treat complex diseases like cancer and neurological disorders with minimal immunogenicity concerns. Rising prevalence of chronic diseases, growing demand for personalized medicine, and advantages of autologous cells over allogeneic cells are some key factors expected to propel demand for autologous cell therapies going forward. However, high costs associated with development and manufacturing along with regulatory challenges are major barriers to the market.
Market Dynamics:
The global autologous cell therapy market is driven by rising geriatric population vulnerable to develop chronic diseases, increasing investments from public and private players to expedite product development, and growing demand for personalized treatment options. However, high development costs, complex manufacturing processes, and stringent regulatory policies are projected to restrain the market growth during the forecast period. Various ongoing clinical trials evaluating efficacy and safety of autologous cell therapies for new indications and development of innovative manufacturing technologies present significant opportunities for existing as well as new market players. Key players are collaborating with academic research institutions to expand applications of these therapies. Asia Pacific presents lucrative market opportunities with growing healthcare infrastructure and increasing healthcare spending in major countries like China and India.
Key Features of the Study:
This report provides in-depth analysis of the global autologous cell therapy market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global autologous cell therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bristol Myers Squibb, Novartis, Gilead Sciences, Kite Pharma, Celgene, Amgen, Takeda Pharmaceutical Company, Merck KGaA, Bluebird Bio, Celyad Oncology, Adaptimmune Therapeutics, Allogene Therapeutics, Athersys, Inc., BrainStorm Cell Therapeutics, and Sorrento Therapeutics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global autologous cell therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global autologous cell therapy market
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Cell-based therapies
- Tissue-based therapies
- Gene therapies
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology
- Cardiovascular diseases
- Neurological disorders
- Orthopedic disorders
- Autoimmune diseases
- Wound healing
- Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Stem cell therapy
- CAR T-cell therapy
- T-cell receptor (TCR) therapy
- Induced pluripotent stem cells (iPSCs)
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Research institutes
- Biotechnology companies
- Pharmaceutical companies
- Others
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Bristol Myers Squibb
- Novartis
- Gilead Sciences
- Kite Pharma
- Celgene
- Amgen
- Takeda Pharmaceutical Company
- Merck KGaA
- Bluebird Bio
- Celyad Oncology
- Adaptimmune Therapeutics
- Allogene Therapeutics
- Athersys, Inc.
- BrainStorm Cell Therapeutics
- Sorrento Therapeutics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Autologous Cell Therapy Market, By Product Type
- Global Autologous Cell Therapy Market, By Application
- Global Autologous Cell Therapy Market, By Technology
- Global Autologous Cell Therapy Market, By End User
- Global Autologous Cell Therapy Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Autologous Cell Therapy Market, By Product Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Cell-based therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Tissue-based therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Gene therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Autologous Cell Therapy Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cardiovascular diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Neurological disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Orthopedic disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Autoimmune diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Wound healing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Autologous Cell Therapy Market, By Technology, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Stem cell therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- CAR T-cell therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- T-cell receptor (TCR) therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Induced pluripotent stem cells (iPSCs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Autologous Cell Therapy Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Research institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Biotechnology companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Pharmaceutical companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Autologous Cell Therapy Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Bristol Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Gilead Sciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Kite Pharma
- Celgene
- Amgen
- Takeda Pharmaceutical Company
- Merck KGaA
- Bluebird Bio
- Celyad Oncology
- Adaptimmune Therapeutics
- Allogene Therapeutics
- Athersys, Inc.
- BrainStorm Cell Therapeutics
- Sorrento Therapeutics
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
